Wednesday, September 23, 2009

KERX Hits New High on Kidney Drug

Keryx (KERX) up 25-40% today, a new high, on positive results for a kidney drug - I bought some on the FDA positive ruling a few days ago .. still only 2.90-3.30, this could SOAR! Great chart now too.
The Reuters story..

Update: KERX closed up only 15%, at 2.70, as it pulled back at the close, either with the mkt, on profit-taking, or just the mm's trying to shake out small investors.. the daily high of 3.30 is not even close to where it should be with two positive drug results in a week.. just my opinion, do your own research and decide for your own bad self..

Disclosure: Long KERX, DNDN, CVM, BSDM

0 comments:

Disclaimer

This is not a solicitation or recommendation to buy or sell any stock. We are not registered investment advisors, and the site does not receive any compensation for any posts, endorsements, or listings. All investments carry risk, and your own individual situation should determine your strategy. Only invest funds you can afford to lose.

The Author at EZines

STEM CELLS EXPRESS

Visitor Map

Related Sites

World Markets Summary

Why We Invest

A company issuing stock gets it's money when the stock goes public, called IPO for Initial Public Offering. However, if the stock takes off due to future expectations, the company can capitalize by issuing more stock and raising money near the current price, so investing in these small biotech companies increases their chances of succeeding by raising enough additonal capital that they don't need to take on debt.

Then when promising drugs are approved and released, the subsequent income produced drives the stock price higher, and all investors and employees benefit and can either invest more in the industry or perhaps realize a goal in life.

1000 DVDs to See

About Me

My Photo
Artist, photographer, composer, author, blogger, metaphysician
©2009, William L. Sinclair, All Rights Reserved

  © Blogger template 'Froggy' by Ourblogtemplates.com 2008

Back to TOP